Search Results

• • 7 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients

  Authors:Caroline Holm, Suresh Rayala, Karin Jirstrom, Olle Stal, Rakesh Kumar, and Goran LandbergFrom:Journal of the National Cancer Institute (Vol. 98, Issue 10) Peer-Reviewed

  May 17, 2006325 words Author abstract, Cli... 60L

   Abstract Only

• Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis

  Authors:Elin Karlsson, Ivana Magic, Josefine Bostner, Christine Dyrager, Fredrik Lysholm, Anna-Lotta Hallbeck, et al.From:PLoS ONE (Vol. 10, Issue 12) Peer-Reviewed

  Dec. 23, 201510,241 words Article 1520LBackground The AKT/mTORC1/S6K pathway is frequently overstimulated in breast cancer, constituting a promising therapeutic target. The benefit from mTOR inhibitors varies, likely as a consequence of tumour...

• Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

  Authors:Xiao-Feng Sun, John M. Carstensen, Hong Zhang, Olle Stal, Sten Wingren, Thomas Hatschek, et al.From:The Lancet (Vol. 340, Issue 8832) Peer-Reviewed

  Dec. 5, 1992307 words Article

   Abstract Only

• Estrogen receptor-[alpha] phosphorylation at serine-118 and tamoxifen response in breast cancer

  Authors:Marleen Kok, Caroline Holm-Wigerup, Michael Hauptmann, Rob Michalides, Olle Stal, Sabine Linn, et al.From:Journal of the National Cancer Institute (Vol. 101, Issue 24) Peer-Reviewed

  Dec. 16, 2009208 words Author abstract

   Abstract Only

• Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer

  Authors:Susann Busch, Lisa Ryden, Olle Stal, Karin Jirstrom, and Goran LandbergFrom:PLoS ONE (Vol. 7, Issue 9) Peer-Reviewed

  Sept. 24, 20126,253 words Report 1560LAuthor(s): Susann Busch 1 , Lisa Rydén 2 , Olle Stål 3 , Karin Jirström 4 , Göran Landberg 1 , 4 , 5 , * Introduction The administration of the anti-estrogen tamoxifen is an adjuvant endocrine therapy for patients...

• 17[beta]-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer

  Authors:Tove Sivik, Cecilia Gunnarsson, Tommy Fornander, Bo Nordenskjold, Lambert Skoog, Olle Stal, et al.From:PLoS ONE (Vol. 7, Issue 7) Peer-Reviewed

  July 6, 20124,041 words Article 1540LAuthor(s): Tove Sivik 1 , * , Cecilia Gunnarsson 2 , 3 , Tommy Fornander 4 , Bo Nordenskjöld 1 , 3 , Lambert Skoog 4 , Olle Stål 1 , 3 , Agneta Jansson 1 Introduction Peripheral intracrine sex steroid synthesis...

• Apoptosis in rectal carcinoma: prognosis and recurrence after preoperative radiotherapy

  Authors:Gunnar C.E. Adell, Hong Zhang, Sofia Evertsson, Xiao-Feng Sun, Olle H.G. Stal, and Bo A. NordenskjoldFrom:Cancer (Vol. 91, Issue 10) Peer-Reviewed

  May 15, 2001 Article

   Citation Only